Barclays
BLUE

Barclays’s bluebird bio BLUE Stock Holding History

Barclays’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-517
Closed -$361K – 4885
2020
Q3 		$361K Buy
+517
New +$403K ﹤0.01% 3462
2020
Q1 		– Sell
-31
Closed -$35K – 6142
2019
Q4 		$35K Buy
31
+8
+35% +$8.7K ﹤0.01% 5843
2019
Q3 		$28K Sell
23
-16
-41% -$24.4K ﹤0.01% 6126
2019
Q2 		$64K Buy
39
+16
+70% +$27.7K ﹤0.01% 5970
2019
Q1 		$47K Sell
23
-8
-26% -$14.1K ﹤0.01% 5921
2018
Q4 		$40K Sell
31
-54
-64% -$82.8K ﹤0.01% 5581
2018
Q3 		$161K Sell
85
-6,029
-99% -$12.5M ﹤0.01% 5174
2018
Q2 		$12.4M Buy
6,114
+5,998
+5,171% +$13.7M 0.01% 1082
2018
Q1 		$256K Sell
116
-386
-77% -$982K ﹤0.01% 4609
2017
Q4 		$1.16M Buy
502
+216
+76% +$439K ﹤0.01% 2971
2017
Q3 		$508K Buy
286
+201
+236% +$281K ﹤0.01% 3608
2017
Q2 		$116K Buy
85
+77
+963% +$92.9K ﹤0.01% 4800
2017
Q1 		$9K Sell
8
-1,582
-99% -$1.61M ﹤0.01% 6099
2016
Q4 		$1.27M Buy
+1,590
New +$1.26M ﹤0.01% 2513

Barclays's BLUE Position: Q3 2025 in Review

Barclays sold out of bluebird bio (BLUE) in Q3 2025, closing a stake of 1 share — an estimated $4 sold.

Barclays first reported a position in BLUE in Q3 2013 and held it in 48 quarters. The position peaked at $18.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold BLUE as of Q3 2025.

  • Barclays reported no remaining bluebird bio position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 1 bluebird bio share in Q3 2025, an estimated $4.
  • Barclays first reported a position in bluebird bio in Q3 2013 and held it in 48 quarters.
  • Barclays's bluebird bio position peaked at $18.1M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held bluebird bio as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.